These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer. Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer. Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265 [TBL] [Abstract][Full Text] [Related]
5. A prospective study of inhibin in granulosa cell tumors of the ovary. Jobling T; Mamers P; Healy DL; MacLachlan V; Burger HG; Quinn M; Rome R; Day AJ Gynecol Oncol; 1994 Nov; 55(2):285-9. PubMed ID: 7959297 [TBL] [Abstract][Full Text] [Related]
6. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary. Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823 [TBL] [Abstract][Full Text] [Related]
7. Total inhibin is a potential serum marker for epithelial ovarian cancer. Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066 [TBL] [Abstract][Full Text] [Related]
8. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307 [TBL] [Abstract][Full Text] [Related]
9. Inhibin as a marker for granulosa-cell tumors. Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M; de Bruijn HW N Engl J Med; 1989 Sep; 321(12):790-3. PubMed ID: 2770810 [TBL] [Abstract][Full Text] [Related]
10. Inhibin forms in serum from postmenopausal women with ovarian cancers. Robertson DM; Cahir N; Burger HG; Mamers P; Groome N Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065 [TBL] [Abstract][Full Text] [Related]
11. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994 [TBL] [Abstract][Full Text] [Related]
12. [Role of total inhibin in diagnosis and monitoring of ovarian cancer in postmenopausal women]. Markova D; Milchev N; Batashki I; Uchikov A Akush Ginekol (Sofiia); 2008; 47(1):16-9. PubMed ID: 18642569 [TBL] [Abstract][Full Text] [Related]
13. Inhibin-producing ovarian granulosa cell tumor as a cause of secondary amenorrhea: case report and review of the literature. Kurihara S; Hirakawa T; Amada S; Ariyoshi K; Nakano H J Obstet Gynaecol Res; 2004 Dec; 30(6):439-43. PubMed ID: 15566459 [TBL] [Abstract][Full Text] [Related]
14. Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. Mom CH; Engelen MJ; Willemse PH; Gietema JA; ten Hoor KA; de Vries EG; van der Zee AG Gynecol Oncol; 2007 May; 105(2):365-72. PubMed ID: 17306349 [TBL] [Abstract][Full Text] [Related]
15. Serum inhibin and disease status in women with ovarian granulosa cell tumors. Boggess JF; Soules MR; Goff BA; Greer BE; Cain JM; Tamimi HK Gynecol Oncol; 1997 Jan; 64(1):64-9. PubMed ID: 8995549 [TBL] [Abstract][Full Text] [Related]
16. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Lambert-Messerlian GM; Steinhoff M; Zheng W; Canick JA; Gajewski WH; Seifer DB; Schneyer AL Gynecol Oncol; 1997 Jun; 65(3):512-6. PubMed ID: 9190984 [TBL] [Abstract][Full Text] [Related]
17. Hormone synthesis and responsiveness of spontaneous granulosa cell tumors in (SWR x SWXJ-9) F1 mice. Gocze PM; Beamer WG; de Jong FH; Freeman DA Gynecol Oncol; 1997 Apr; 65(1):143-8. PubMed ID: 9103404 [TBL] [Abstract][Full Text] [Related]
18. Inhibin as a diagnostic marker for ovarian cancer. Robertson DM; Pruysers E; Jobling T Cancer Lett; 2007 Apr; 249(1):14-7. PubMed ID: 17320281 [TBL] [Abstract][Full Text] [Related]
19. Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer. Pylväs M; Puistola U; Laatio L; Kauppila S; Karihtala P Anticancer Res; 2011 Apr; 31(4):1411-5. PubMed ID: 21508394 [TBL] [Abstract][Full Text] [Related]
20. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gurusinghe CJ; Healy DL; Jobling T; Mamers P; Burger HG Gynecol Oncol; 1995 Apr; 57(1):27-32. PubMed ID: 7705698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]